Related Experiment Video

Updated: Aug 2, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.2K

Spontaneous pulmonary hematoma in patients with COVID-19

C Lozano1, A González1, M Andreu1

  • 1UDIAT-Centro Diagnóstico, Servicio de Diagnóstico por la Imagen, Parc Taulí Hospital Universitario, Instituto de Investigación e Innovación Parc Taulí (I3PT), Sabadell, Barcelona, Spain.

Radiologia
|April 14, 2023
PubMed

Insights

Two patients with COVID-19 developed spontaneous pulmonary hematoma while on anticoagulant therapy. This rare but serious complication requires consideration in managing these patients.

Area of Science:

  • Medicine
  • Pulmonology
  • Hematology

Background:

  • COVID-19 is a global pandemic with significant public health implications.
  • Coagulation abnormalities are recognized complications of COVID-19, often leading to a prothrombotic state.
  • Hemorrhagic complications, particularly in anticoagulated patients, have been reported in COVID-19 cases.

Purpose of the Study:

  • To describe spontaneous pulmonary hematoma in patients with COVID-19 undergoing anticoagulant treatment.
  • To raise awareness of this uncommon but significant complication.

Main Methods:

  • Case report presentation of two patients with COVID-19.
  • Review of clinical presentation and management of spontaneous pulmonary hematoma.
  • Discussion of the interplay between COVID-19, anticoagulation, and hemorrhagic complications.

Main Results:

  • Two cases of spontaneous pulmonary hematoma were identified in COVID-19 patients on anticoagulation.
  • These cases highlight a potential hemorrhagic risk in this patient population.

Conclusions:

  • Spontaneous pulmonary hematoma is an uncommon complication in anticoagulated COVID-19 patients.
  • Clinicians should consider this diagnosis in the differential for bleeding events in these patients.

Keywords:
AnticoagulantsCOVID-19Covid-19Fármacos anticoagulantesHematoma pulmonarPulmonary hematoma

More Related Videos

A Porcine Model of Acute Autologous Pulmonary Embolism07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

456
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots07:57

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

389

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
14
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
272
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
230
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
17
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
305